|
|
(27 intermediate revisions not shown) |
Line 26: |
Line 26: |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/C4HSL-dependent_3OC12HSL_production" style="width:400px; margin-left:-135px;">C4HSL-dependent 3OC12HSL production</a></li> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/3OC12HSL-dependent_C4HSL_production" style="width:400px; margin-left:-135px;">3OC12HSL-dependent C4HSL production</a></li> |
- | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Symbiosis confirmation by co-culture </a></li> | + | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Experiment/Symbiosis_confirmation_by_co-culture" style="width:400px; margin-left:-135px;">Mutualism Confirmation ~Co-culture Assay~</a></li> |
- |
| + | |
| </ul> | | </ul> |
| </li> | | </li> |
- | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling">Modeling</a> | + | <li><a href="#">Modeling</a> |
| <ul> | | <ul> |
| <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Overview" style="width:400px; margin-left:-135px;">Overview</a></li> | | <li><a href="https://2014.igem.org/Team:Tokyo_Tech/Modeling/Overview" style="width:400px; margin-left:-135px;">Overview</a></li> |
Line 65: |
Line 64: |
| <h2 class="title">Parts</h2> | | <h2 class="title">Parts</h2> |
| | | |
- | <span class="meta">Each part give us a whole new experience </span> | + | <span class="meta">Each part gives us a whole new experience </span> |
| <div class="entry-long"> | | <div class="entry-long"> |
| | | |
Line 170: |
Line 169: |
| <td><h2>2. Best New Composite Part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a></span></h2></td> | | <td><h2>2. Best New Composite Part<span class="head">: <a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a></span></h2></td> |
| </tr> | | </tr> |
- | <tr>
| + | <td><p class="head">•Prhl(RL)-CmR-LasI (<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>)</p></td> |
- | <td><p class="head">• Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797>BBa_K1529797</a>)</p></td>
| + | |
| </tr> | | </tr> |
| + | |
| + | <tr> |
| + | |
| <tr> | | <tr> |
- | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.)</p> | + | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K1529300">BBa_K1529300</a>, <a href="http://parts.igem.org/Part:BBa_K395160">BBa_K395160</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0078">BBa_C0078</a>. Prhl(RL) promoter has no leakage and higher expression than Prhl promoter (<a href="http://parts.igem.org/Part:BBa_R0071">BBa_R0071</a>). CmR and LasI are inserted into the downstream of the promoter</p> |
- | <p class="info-18"This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> | + | <p class="info-18"This is the first BioBrick part that succeeded in C4HSL dependent CmR and 3OC12HSL production. Using this part with the plasmid that is constitutively expressing RhlR, we succeeded in confirming RhlR activates the expression of CmR and LasI in the presence of C4HSL. </p> |
- | <p class="info-18">To confirm C4HSL production, we measured the expression of GFP in reporter cells by flow cytometer. (Fig. 5-1-2-2.)</p> | + | <p class="info-18"> |
| + | To confirm CmR production, we added chloramphenicol into the medium containing Prhl(RL)-CmR-LasI cell and measured optical density for about 8 h to estimate the concentration of the cell. (Fig. 5-1-2-1.) |
| + | </p> |
| <p class="info-18"> Moreover, by co-culturing the cells containing this part with the cells containing 3OC12HSL dependent C4HSL producer part (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>), we succeeded in constructing a positive feedback system. </p></td> | | <p class="info-18"> Moreover, by co-culturing the cells containing this part with the cells containing 3OC12HSL dependent C4HSL producer part (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>), we succeeded in constructing a positive feedback system. </p></td> |
| </tr> | | </tr> |
Line 189: |
Line 192: |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td><p class="head">Prhl(RL)-CmR-LasI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>)</p></td> | + | |
| + | |
| + | <tr> |
| + | <td><p class="head">• Plux-CmR-RhlI (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>)</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
| <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.) <br /> | | <td><p class="info-18">We constructed this part by combining <a href="http://parts.igem.org/Part:BBa_K395162">BBa_K395162</a>, <a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a> and <a href="http://parts.igem.org/Part:BBa_C0070">BBa_C0070</a>. (CmR is Chloramphenicol resistance.) <br /> |
| This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> | | This is the first BioBrick part that succeeded in 3OC12HSL dependent CmR and C4HSL production. In our experiment, we used 3OC12HSL instead of 3OC6HSL as an inducer in order to circumvent crosstalk. Using this part with the plasmid that is constitutively expressing LuxR, we succeeded in confirming LuxR activates the expression of CmR and RhlI in the presence of 3OC12HSL. </p> |
- | <p class="info-18">To confirm C4HSL production, we measured the expression of GFP in reporter cells by flow cytometer. (Fig. 5-1-2-2.)</p></td> | + | <p class="info-18">To confirm C4HSL production, we measured the expression of GFP in reporter cells by flow cytometer. (Fig. 5-1-2-2).</p></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
Line 207: |
Line 213: |
| <td> </td> | | <td> </td> |
| </tr> | | </tr> |
- | <tr>
| |
| <td><h2>3. Best Part Collection: <span class="head"><a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a><a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow"></a></span> </h2></td> | | <td><h2>3. Best Part Collection: <span class="head"><a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>, <a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a><a href="http://parts.igem.org/Part:BBa_K1139201" rel="nofollow"></a></span> </h2></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
- | <td> </td> | + | <td><p class="info-18">Using these parts enable us to accomplish mutualism. The results of the co-culture assay is shown in Fig. 5-1-2-3. Company’s characteristics are C4HSL-dependent survival and 3OC12HSL production (<a href="http://parts.igem.org/Part:BBa_K1529302">BBa_K1529302</a>), and Customer’s characteristics are the opposite from Company’s (<a href="http://parts.igem.org/Part:BBa_K1529797">BBa_K1529797</a>). From these characteristics, the symbiosis between the two cells can be established.</p></td> |
| + | </tr> |
| + | <tr> |
| + | <td><p class="info-18">Two types of fluorescent proteins were used to trace the growth of each cells in our symbiosis experiments. We constructed the Company cell containing GFP and Customer cell containing RFP. By measuring the OD of the cells expressing GFP with flow cytometer, the symbiosis was detected.</p><td> |
| + | </tr> |
| + | <tr> |
| + | <td><p class="info-18">Using these parts enable us to accomplish mutualism. The results of the co-culture assay is shown in Fig. 5-1-2-3. Company’s By looking at the fluorescence intensity of GFP in Company cells, the optical density increased faster in co-culture than single culture.From this point, we can say that Company and Customer actually mutualize in the medium. |
| + | </p></td> |
| + | </tr> |
| + | <tr> |
| + | <td><div align="center"><a href="https://2014.igem.org/File:Tokyo_Tech_Fig5-1-2-3.png"><img src="https://static.igem.org/mediawiki/2014/0/08/Tokyo_Tech_Fig5-1-2-3.png" height="400" /></a></div></td> |
| + | </tr> |
| + | <tr> |
| + | <td><div align="center"><strong>Fig. 5-1-2-3.</strong> The result of co-culture assay </div></td> |
| </tr> | | </tr> |
| <tr> | | <tr> |